CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 13 enrolled
Drug / intervention
Mindfulness and Interoceptive Exposurebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02133365
NCT02133365N/ACompleted

Atrial Fibrillation, Cardiac Symptoms, and Anxiety

Brigham and Women's Hospital·interventional·Posted May 8, 2014·Updated Nov 6, 2025

In Brief

A clinical study evaluating Mindfulness and Interoceptive Exposure for Atrial Fibrillation and Anxiety. Completed, enrolled 13 participants across 1 site.

Detailed Summary

This is an investigation of a mindfulness and interoceptive exposure intervention in patients with atrial fibrillation, to decrease anxiety sensitivity, symptom burden, and atrial fibrillation recurrence.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 8, 2014
Enrollment StartSep 1, 2014
Primary CompletionMar 1, 2017
Study CompletionJan 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 12.2 years ago

Interventions

Mindfulness and Interoceptive Exposurebehavioral

The Mindfulness and Interoceptive Exposure intervention will be delivered in 4-5 manualized, individualized therapy sessions, of 1.5 hours - 2 hours each. The intervention is comprised of four established cognitive-behavioral strategies: psychoeducation, mindfulness, interoceptive exposure and skills generalization.